[0001] The invention relates to fibrous structures, for example fibrous mats or fibrous
tubular structures. More particularly but not exclusively, the invention relates to
fibrous synthetic vascular grafts.
[0002] In the past, it has been proposed to produce fibrous structures such as mats by a
process using electrostatic attraction, where a polymer such as polyurethane in solution
is ejected from a fine nozzle towards a surface, between which surface and the nozzle
exists an electrostatic potential. Between the nozzle and the surface, fibres of the
polymer are formed and the fibres are attracted to the surface. This process has been
adapted to make tubular fibrous structures usable as synthetic vascular grafts by
providing the surface in the form of a rotating mandrel so that a fibrous tube is
gathered around the mandrel.
[0003] The electrostatic spinning process is described in some detail in U.S. Patent Specification
No. 4044404 and proposals to use the electrostatic spinning process for making synthetic
vascular grafts have been made,.for example, in a paper by Annis et al in 1978 (Trans.
Am. Soc. Intern. Organs). The microstructure of the fibrous material produced-during
electrostatic spinning is also described in the Annis et al paper. More recently,
developments have been made in matching properties of synthetic vascular grafts to
in vivo conditions, as in our British Patent Application No. 8217487 published under
No. 2120946A and in controlling anisotropic properties of grafts in our British Patent
Application No. 8216066, published under No.2121286A.
[0004] According to the invention there is provided an integral fibrous structure of a plurality
of continuous, polymeric filaments, individual filaments extending from one side of
the structure to the opposite side of the structure, the portions of the filaments
on one side of the structure being of a first polymeric composition and the portions
of the filaments on the opposite side of the structure being of a second polymeric
composition different from-the first polymeric composition.
[0005] The term "different polymeric composition" is intended to cover a variation of the
composition of the filaments where the polymer itself does not change across the structure
but, for example, an additive is present in the composition at one side of the structure
but not present at the opposite side of the structure.
[0006] The structure may comprise a transition area between the sides of the structure,
and the portions of the filaments in the transition area may have a polymeric composition
comprising a mixture of the first and second polymeric compositions.
[0007] ,The polymeric composition of the filaments may vary progressively between the two
sides of the structure, and the composition of the portions of the filaments in the
transition area adjacent the one side of the structure may contain a large proportion
of the first polymeric composition and the portions of the filaments adjacent the
opposite side of the structure may contain a large proportion of the second polymeric
composition.
[0008] Alternatively, the composition of the filaments may change abruptly to provide distinct
layers within the structure having different polymeric compositions. There may be
more than two layers in the structure.
[0009] The structure may be in the form of a mat, or may be a tubular member.
[0010] When the structure is a tubular member, the portions of the filaments at the inner
surface of the tubular member are preferably of the first polymeric composition to
provide compatibility with material with which the inner surface will come into contact,
and the portions of the filaments at the outer surface of the tubular member are preferably
of the second polymeric composition to provide desirable strength characteristics
and other physical properties to the tubular member."
[0011] The tubular member may be cut to provide one or more segmental elements from the
tubular wall. If the internal diameter of the tubular member is large enough, for
example a few centimetres, the segmental element or elements will tend towards being
planar, and may be used as pledgets.
[0012] The invention further provides a method of forming an integral fibrous structure
according to the invention, which method comprises the steps of directing filaments
of a first polymeric composition at a surface to start building up a fibrous structure
of the first polymeric composition, and altering the composition of the filaments
during production thereof such that the portions of the filaments at the side of the
structure remote from the surface is of the second polymeric composition.
[0013] The composition of the filaments may be changed abruptly or may be varied gradually
across the structure.
[0014] By way of example, one embodiment of a fibrous structure and its method of production
according to the invention will now be described with reference to the accompanying
drawings, in which:-
Figure 1 is a diagrammatic view of apparatus. for producing a tubular fibrous structure;
Figure 2 is a graph illustrating concentration of one polymeric composition in a structure
wall; and
Figure 3 is a part sectional view of a tubular fibrous structure produced by the apparatus
of Figure 1.
[0015] Figure 1 shows diagrammatically apparatus for electrostatically spinning a synthetic
vascular graft. Polymer solution is ejected from capillary needles 10 towards an electrostatically
charged mandrel 11 rotating at several thousand revolutions per minute, for example
5000 r.p.m. Typically, the mandrel 11 is at a potential of -12kV with respect to the
needles 10. As polymer solution leaves the needles.10, polymer filaments form and
these filaments are attracted to the rotating electrostatically charged mandrel 11
to form a.fibrous structure around the mandrel. When the fibrous structure has been
built up, the structure is removed from the mandrel to provide a fibrous tube.
[0016] Mechanical properties of the tubular fibrous structure formed on the mandrel 11 can
be controlled by variation of the speed of rotation of the mandrel, the type of polymer
used and by altering the potential of auxiliary electrodes 12.
[0017] The capillary needles 10 are supplied with polymer solution from a manifold 13, the
manifold 13 being supplied by tubes 14 and 15 meeting in a T connector 16. Both tubes
14 and 15 include a flexible coil 17 and 18 respectively. The tube 14 has a valve
19 and the tube 15 has a valve 20 to enable the respective tubes to be closed. Control
lines 21 and 22 control opening and closing of the valves 19 and 20.
[0018] The tube 14 is supplied from a first air-ram driven syringe 23 and the tube 15 is
fed from a second air-ram driven syringe 24 and the apparatus enables polymer solution
from either syringe 23 or syringe 24 to be ejected from the needles 10 towards the
mandrel 11. A purge line 25 including a closure valve 26 allows purging of the manifold
13.
[0019] The apparatus of Figure 1 allows formation of an integral, uninterrupted fibrous
structure of continuous polymeric filaments around the surface of the mandrel 11,
the portions of the filaments at the inside surface having a different polymeric composition
from the portions of the filaments of the outside surface of the fibrous structure.
This can be advantageous when the tubular fibrous structures are used for, for example,
synthetic vascular grafts. It has been found that different polymers have different
haemocompatibilities and that different polymers have different strength characteristics.
In a particular example, one polyurethane has advantageous haemocompatibility but
poor elastic properties, exhibiting high creep. A second polyurethane having a higher
Young's modulus has satisfactory strength properties but poor haemocompatibility.
The apparatus of Figure 1, as will be described in the following example, allows production
of a synthetic vascular graft having a thin inner lining of the first polyurethane
on a wall of the second polyurethane, the graft, however, being formed of fibres spun
continuously, with individual fibres changing composition between their ends to provide
an integral, uninterrupted, fibrous structure.
EXAMPLE
[0020] The sequence of operation of the apparatus of Figure 1 in this example is as follows:-
1. Fill the syringe 24 with a first polymer dope and fill the syringe 23 with a second
polymer dope.
2. Using the valves 19, 20 and 26, prime the tube 14 with the second polymer dope
and then prime the tube 15 and the manifold 13 with first polymer dope.
3. With the valves 19 and 26 closed, commence electrostatic spinning with the first
polymer dope contained in the syringe 24, the tube 15 and the manifold 13.
4. After a time, open the valve 19 and close the valve 20. After expression of remaining
first polymer dope out of the needles 10, spinning continues in an uninterrupted fashion
with second polymer.
5. The abruptness of the transition from the first polymer dope to the second polymer
dope is a function of the rate of flow of second polymer dope into the manifold 13
and the volume of the manifold 13, needles 10 and T junction 16. This transition can
be controlled by the use of the valve 26 on the purge line 25 which can be used to
vent at a variable rate remaining first polymer dope. The concentration gradient of
the two polymers in the graft wall will follow a defined, controllable relationship
as illustrated in Figure 2 where the solid line shows an abrupt change where the valve
26 is used and the chain line shows a slow change.
[0021] A further development of the first example arises in that on porosity testing, it
was found that the permeability of the bi-layer graft was too high. A situation was
envisaged where transmural flow of blood or plasma might lead to excessive blood platelet
capture on the inner surface and compromise the thromboresistance of the graft. The
solution here would be to include an outer layer of a third polymer, for example one
having a high Young's modulus, which when deposited on the second polymer produces
a dense matrix with low interstitial volume. In this way, the overall graft wall permeability
is determined by this outer layer. Figure 3 shows in cross section part of a bi-layer
graft. The further development would mean addition of an outer layer of a third polymer
to the graft shown in Figure 3.
[0022] Many different polymers can be used in the electrostatic spinning process. Several
examples are given in U.S. Patent Specification No. 4044404, such as polyurethanes,
polyamides and polyacrylonitrile, all of which can be spun from solution, and polytetrafluorethylene
and polyesters which may be spun from dispersion. Water soluble polymers such as polyvinyl
alcohol, polyvinyl pyrrolidone and polyethylene oxide may be spun from aqueous solution.
[0023] The constraint on the fibrous structure and method of production according to the
invention is that the two or more polymers used to vary the composition of the filaments
during the spinning process must be either dispersible or alternatively soluble in
the same solvent system. Thus it would be possible to spin with different polyurethanes,
as used in the preferred example, or with different polyesters in dispersion, but
it would not be possible to change, for example, from a polyurethane to a polyester.
[0024] It will also be appreciated that the properties of a particular polymeric composition
may be varied by the presence of an additive, even if the polymeric composition itself
does not vary along the length of a filament. For example, a silicone lubricant could
be added to a polyurethane polymer and spun' as the inner surface of a graft, the
outer surface of the graft being the same polyurethane without the silicone lubricant.
Such an example is included in the scope of the invention.
[0025] The advantage of the embodiments of grafts hereinbefore described are that the different
layers can be optimised for particular properties, either in its morphology (e.g.
porosity, pore shape, fibre size) or in its chemistry (e.g. type of polymer, presence
of drug. For example, a drug such as heparin or prostacylin may be included in the
inner layer to improve the property with regard to contacting blood). If such layers
are built up discontinuously, lines of weakness exist between the contiguous surfaces
and delamination is likely to occur at quite low mechanical stresses. The advantage
of the method hereinbefore described is that it builds different layers into an integrally
formed fibrous structure so that the successive wall components are merged in a well
controlled way.
[0026] An illustration of the advantage of a bi-layer graft according to the example described
is that in an initial canine common carotid trial, a 300% improvement in patency over
non-laminated, single component grafts was found. Other possibilities, for example
pledgets and drug releasing vascular grafts are also quite possible.
[0027] It will be appreciated that while the embodiments described relate to tubular fibrous
structures for use as vascular grafts, the invention is equally applicable to planar
fibrous structures such as mats and that such alternative structures would have wide
applications.
1. An integral fibrous structure of a plurality of continuous polymeric filaments,
individual filaments extending from one side of the structure to the opposite side
of the structure, the portions of the filaments on one side of the structure being
of a first polymeric composition and the portions of the filaments on the opposite
side of the structure being of a second polymeric- composition different from the
first polymeric composition.
2. A fibrous structure as claimed in Claim 1 comprising a transition area between
the sides of the structure, the portions of the filaments in the transition area having
a polymeric composition comprising a mixture of the first and second polymeric compositions.
3. A fibrous structure as claimed in Claim 2 wherein the composition of the portions
of the filaments in the transition area adjacent the one side of the structure contain
a large proportion of the first polymeric composition and the portions of the filaments
in the transition area adjacent the opposite side of the structure contain a large
percentage of the second polymeric composition.
4. A fibrous structure as claimed in any preceding Claim wherein the polymeric composition
of the structure varies progressively between the two sides of the structure.
5. A fibrous structure as claimed in Claim 1 wherein the composition of the filaments
changes abruptly to provide distinct layers within the structure having different
polymeric compositions.
6. A fibrous structure as claimed in any preceding Claim comprising a multiplicity
of changes in polymeric composition of the fibres.
7. A fibrous structure as claimed in any preceding Claim in the form of a mat.
8. A fibrous structure as claimed in any one of Claims 1 to 7 in the form of a tubular
member.
9. A fibrous structure as claimed in Claim 8 wherein the portions of the filaments
at the inner surface of the tubular member are of the first polymeric composition
to provide compatability with material with which the inner surface will come into
contact, and the portions of the filaments at the outer surface of the tubular member
are of the second polymeric composition to provide desirable strength characteristics
and other physical properties to the tubular member.
10. A fibrous structure comprising a tubular member as claimed in Claim 8 or Claim
9 cut to provide one or more segmental elements from the tubular wall.
11. A method of forming an integral fibrous structure as claimed in any preceding
Claim, which method comprises the steps of directing filaments of a first polymeric
composition at a surface to start building up a fibrous structure of the first polymeric
composition, and altering the composition of the filaments during production thereof
such that the portions of the filaments at the side of the structure remote from the
surface is of the second polymeric composition.
12. A method as claimed in Claim 11 wherein the composition of the filaments is changed
abruptly.
13. A method as claimed in Claim 11 wherein the composition of the filaments is varied
gradually across the structure.
14. A fibrous structure made by a method as claimed in any one of Claims 11 to 13.